Meta-analysis of genome-wide association data identifies a risk locus for major mood disorders on 3p21.1.
paper
Cited
Public
- Authors
- McMahon, Francis J; Akula, Nirmala; Schulze, Thomas G; Muglia, Pierandrea; Tozzi, Federica; Detera-Wadleigh, Sevilla D; Steele, C J M; Breuer, René; Strohmaier, Jana; Wendland, Jens R; Mattheisen, Manuel; Mühleisen, Thomas W; Maier, Wolfgang; Nöthen, Markus M; Cichon, Sven; Farmer, Anne; Vincent, John B; Holsboer, Florian; Preisig, Martin; Rietschel, Marcella; Bipolar Disorder Genome Study (BiGS) Consortium
- Year
- 2010
- Journal
- Nature genetics
- PMID
- 20081856
- DOI
- 10.1038/ng.523
- PMCID
- PMC2854040
The major mood disorders, which include bipolar disorder and major depressive disorder (MDD), are considered heritable traits, although previous genetic association studies have had limited success in robustly identifying risk loci. We performed a meta-analysis of five case-control cohorts for major mood disorder, including over 13,600 individuals genotyped on high-density SNP arrays. We identified SNPs at 3p21.1 associated with major mood disorders (rs2251219, P = 3.63 x 10(-8); odds ratio = 0.87; 95% confidence interval, 0.83-0.92), with supportive evidence for association observed in two out of three independent replication cohorts. These results provide an example of a shared genetic susceptibility locus for bipolar disorder and MDD.
a. Manhattan plot of the meta-analysis results, generated by Haploview 4.0. Physical position is shown along the x-axis, -log (meta-p-value) is shown along the y-axis, and each chromosome is shown in a distinct color. The red guideline indicates the threshold of genome-wide significance (7.2 ×10−8). b. Detail of the associated region, generated by SNAP 2.0. Physical position and gene annotations (HapMap release 22) are shown along the x-axis, -log (meta-p-value) is shown on the left y-axis, recombination rate (CEU) on the right y-axis. c. Linkage disequilibrium (r2) as estimated from HapMap 3 phased genotypes, generated by UCSC Genome Browser. Darker red indicates higher values.
1–9 of 9
| Name | Type |
|---|---|
| bipolar disorder | phenotype |
| blood pressure | phenotype |
| dorsolateral prefrontal cortex | anatomy |
| European ancestry | cohort |
| FAM-labeled local | drug |
| FAM-labeled probe local | drug |
| GAIN-MDD | cohort |
| German sample | cohort |
| HapMap Phase 2 SNPs local | variant |
| healthy controls | cohort |
| Illumina platform | drug |
| MaCH | drug |
| mood disorders | phenotype |
| NIMH bipolar disorder sample local | cohort |
| NIMH-BP local | cohort |
| NIMH control sample local | cohort |
| PBRM1 | gene |
| PGK1 | gene |
| Plink | drug |
| Roche LightCycler 480 local | drug |
| Roche LightCycler 480 Probes master mix local | drug |
| rs2251219 | variant |
| schizophrenia | phenotype |
| SNP | cohort |
| Stanley Medical Research Institute local | cohort |
| STEP-BD | cohort |
| STEP-BD sample local | cohort |
| Transcriptor First Strand cDNA Synthesis kit local | drug |
No uploaded files.
Not in any collection.
In this knowledge base
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| Ultra-high-dimensional threshold selection for quantile feature screening with false discovery rate error rate control: a case study on high blood pressure analysis. | Sanni SA et al. | — | 2026 | → |
| Association of PBRM1 rs2251219 with major depressive disorder and biochemical variables in a Taiwanese cohort. | Chou KJ et al. | — | 2025 | → |
| Human mood disorder risk gene Synaptotagmin-14 contributes to mania-like behaviors in mice. | Zhang Y et al. | — | 2025 | → |
| Identifying novel protein biomarkers with cross-psychiatric disorders effects and potential intervention targets: Evidence from proteomic-Mendelian randomization. | Zhang R et al. | — | 2025 | → |
| Shared genetic architecture and bidirectional clinical risks within the psycho-metabolic nexus. | Guo X et al. | — | 2025 | → |
| Accounting for heterogeneity due to environmental sources in meta-analysis of genome-wide association studies | Wang S et al. | — | 2024 | — |
| Accounting for heterogeneity due to environmental sources in meta-analysis of genome-wide association studies. | Wang S et al. | — | 2024 | → |
| Contribution of rare variants to heritability of a disease is much greater than conventionally estimated: modification of allele distribution model. | Nagao Y | — | 2024 | → |
| NEK4 modulates circadian fluctuations of emotional behaviors and synaptogenesis in male mice. | Yang ZH et al. | — | 2024 | → |
| Identification of a psychiatric risk gene NISCH at 3p21.1 GWAS locus mediating dendritic spine morphogenesis and cognitive function. | Yang ZH et al. | — | 2023 | → |
| CADPS functional mutations in patients with bipolar disorder increase the sensitivity to stress. | Sitbon J et al. | — | 2022 | → |
| Assessment of suicide attempt and death in bipolar affective disorder: a combined clinical and genetic approach. | Monson ET et al. | — | 2021 | → |
| Association study of <i>BDNF</i> Val66Met gene polymorphism with bipolar disorder and lithium treatment response in Indian population. | Paul P et al. | — | 2021 | → |
| Genome-wide differentially methylated genes associated with posttraumatic stress disorder and longitudinal change in methylation in rape survivors. | Nöthling J et al. | — | 2021 | → |
| New and sex-specific migraine susceptibility loci identified from a multiethnic genome-wide meta-analysis. | Choquet H et al. | — | 2021 | → |
| Predicting the risk and timing of major mood disorder in offspring of bipolar parents: exploring the utility of a neural network approach. | Cooper A et al. | — | 2021 | → |
| Therapy response prediction in major depressive disorder: current and novel genomic markers influencing pharmacokinetics and pharmacodynamics. | Shalimova A et al. | — | 2021 | → |
| An atlas of genetic correlations between psychiatric disorders and human blood plasma proteome. | Cheng S et al. | — | 2020 | → |
| Integrative analyses prioritize GNL3 as a risk gene for bipolar disorder. | Meng Q et al. | — | 2020 | → |
| Novel genetic susceptibility loci identified by family based whole exome sequencing in Han Chinese schizophrenia patients. | Li M et al. | — | 2020 | → |
| The genetics of bipolar disorder. | Gordovez FJA et al. | — | 2020 | → |
| The genome-wide risk alleles for psychiatric disorders at 3p21.1 show convergent effects on mRNA expression, cognitive function, and mushroom dendritic spine. | Yang Z et al. | — | 2020 | → |
| Association of <i>SYNE1</i> locus with bipolar disorder in Chinese population. | Li W et al. | — | 2019 | → |
| Biomarkers for bipolar disorder: current status and challenges ahead. | Teixeira AL et al. | — | 2019 | → |
| Multivariate analysis of genome-wide data to identify potential pleiotropic genes for five major psychiatric disorders using MetaCCA. | Jia X et al. | — | 2019 | → |
| Unravelling the genetic basis of schizophrenia and bipolar disorder with GWAS: A systematic review. | Prata DP et al. | — | 2019 | → |
| Detecting significant genotype-phenotype association rules in bipolar disorder: market research meets complex genetics. | Breuer R et al. | — | 2018 | → |
| Exome sequencing of a large family identifies potential candidate genes contributing risk to bipolar disorder. | Zhang T et al. | — | 2018 | → |
| Further Evidence of an Association between <i>NCAN</i> rs1064395 and Bipolar Disorder. | Wang L et al. | — | 2018 | → |
| Genetic variant for behavioral regulation factor of executive function and its possible brain mechanism in attention deficit hyperactivity disorder. | Sun X et al. | — | 2018 | → |
| <i>VRK2</i>, a Candidate Gene for Psychiatric and Neurological Disorders. | Li M et al. | — | 2018 | → |
| Molecular hypotheses to explain the shared pathways and underlying pathobiological causes in catatonia and in catatonic presentations in neuropsychiatric disorders. | Peter-Ross EM | — | 2018 | → |
| Replicated associations of FADS1, MAD1L1, and a rare variant at 10q26.13 with bipolar disorder in Chinese population. | Zhao L et al. | — | 2018 | → |
| The cAMP responsive element-binding (CREB)-1 gene increases risk of major psychiatric disorders. | Xiao X et al. | — | 2018 | → |
| The protocadherin 17 gene affects cognition, personality, amygdala structure and function, synapse development and risk of major mood disorders. | Chang H et al. | — | 2018 | → |
| Application of induced pluripotent stem cells to understand neurobiological basis of bipolar disorder and schizophrenia. | Liu YN et al. | — | 2017 | → |
| Common variants at 2q11.2, 8q21.3, and 11q13.2 are associated with major mood disorders. | Xiao X et al. | — | 2017 | → |
| Diversity in non-repetitive human sequences not found in the reference genome. | Kehr B et al. | — | 2017 | → |
| Evaluation of European Schizophrenia GWAS Loci in Asian Populations via Comprehensive Meta-Analyses. | Xiao X et al. | — | 2017 | → |
| Identification of a Bipolar Disorder Vulnerable Gene CHDH at 3p21.1. | Chang H et al. | — | 2017 | → |
| Longitudinal differences in white matter integrity in youth at high familial risk for bipolar disorder. | Ganzola R et al. | — | 2017 | → |
| Physical Activity Modulates Common Neuroplasticity Substrates in Major Depressive and Bipolar Disorder. | Phillips C | — | 2017 | → |
| BDNF Val66Met polymorphism and bipolar disorder in European populations: A risk association in case-control, family-based and GWAS studies. | Li M et al. | — | 2016 | → |
| Identification of the BRD1 interaction network and its impact on mental disorder risk. | Fryland T et al. | — | 2016 | → |
| Impact of a cis-associated gene expression SNP on chromosome 20q11.22 on bipolar disorder susceptibility, hippocampal structure and cognitive performance. | Li M et al. | — | 2016 | → |
| The role of protein intrinsic disorder in major psychiatric disorders. | Tovo-Rodrigues L et al. | — | 2016 | → |
| A Novel Anxiety and Affective Spectrum Disorder of Mind and Body-The ALPIM (Anxiety-Laxity-Pain-Immune-Mood) Syndrome: A Preliminary Report. | Coplan J et al. | — | 2015 | → |
| Comparative genome-wide association studies of a depressive symptom phenotype in a repeated measures setting by race/ethnicity in the Multi-Ethnic Study of Atherosclerosis. | Ware EB et al. | — | 2015 | → |
| Copy number variations play important roles in heredity of common diseases: a novel method to calculate heritability of a polymorphism. | Nagao Y | — | 2015 | → |
| Epilepsy and bipolar disorder. | Knott S et al. | — | 2015 | → |
| Examining gene-environment interactions in comorbid depressive and disruptive behavior disorders using a Bayesian approach. | Adrian M et al. | — | 2015 | → |
| Explore the Features of Brain-Derived Neurotrophic Factor in Mood Disorders. | Yeh FC et al. | — | 2015 | → |
| Genome-wide association study of behavioural and psychiatric features in human prion disease. | Thompson AG et al. | — | 2015 | → |
| Innate immune response is differentially dysregulated between bipolar disease and schizophrenia. | de Baumont A et al. | — | 2015 | → |
| MGAS: a powerful tool for multivariate gene-based genome-wide association analysis. | Van der Sluis S et al. | — | 2015 | → |
| A genome-wide association analysis of a broad psychosis phenotype identifies three loci for further investigation. | Psychosis Endophenotypes International Consortium et al. | — | 2014 | → |
| Common variant at 16p11.2 conferring risk of psychosis. | Steinberg S et al. | — | 2014 | → |
| Data use under the NIH GWAS data sharing policy and future directions. | Paltoo DN et al. | — | 2014 | → |
| Genetics of Psychosis in Alzheimer Disease. | DeMichele-Sweet MA et al. | — | 2014 | → |
| Genome-wide association study of bipolar disorder in Canadian and UK populations corroborates disease loci including SYNE1 and CSMD1. | Xu W et al. | — | 2014 | → |
| Genomic view of bipolar disorder revealed by whole genome sequencing in a genetic isolate. | Georgi B et al. | — | 2014 | → |
| Integrated neurobiology of bipolar disorder. | Maletic V et al. | — | 2014 | → |
| Investigating the genetic variation underlying episodicity in major depressive disorder: suggestive evidence for a bipolar contribution. | Ferentinos P et al. | — | 2014 | → |
| Investigation of manic and euthymic episodes identifies state- and trait-specific gene expression and STAB1 as a new candidate gene for bipolar disorder. | Witt SH et al. | — | 2014 | → |
| MicroRNA 135 is essential for chronic stress resiliency, antidepressant efficacy, and intact serotonergic activity. | Issler O et al. | — | 2014 | → |
| Proteomic enrichment analysis of psychotic and affective disorders reveals common signatures in presynaptic glutamatergic signaling and energy metabolism. | Gottschalk MG et al. | — | 2014 | → |
| Aberrant executive attention in unaffected youth at familial risk for mood disorders. | Belleau EL et al. | — | 2013 | → |
| A large-scale candidate gene analysis of mood disorders: evidence of neurotrophic tyrosine kinase receptor and opioid receptor signaling dysfunction. | Deo AJ et al. | — | 2013 | → |
| A mega-analysis of genome-wide association studies for major depressive disorder. | Major Depressive Disorder Working Group of the Psychiatric GWAS Consortium et al. | — | 2013 | → |
| Association at SYNE1 in both bipolar disorder and recurrent major depression. | Green EK et al. | — | 2013 | → |
| Comparison of gene expression profiles in the blood, hippocampus and prefrontal cortex of rats. | Witt SH et al. | — | 2013 | → |
| Converging Evidence for Epistasis between ANK3 and Potassium Channel Gene KCNQ2 in Bipolar Disorder. | Judy JT et al. | — | 2013 | → |
| Disorders and borders: psychiatric genetics and nosology. | Smoller JW | — | 2013 | → |
| Genetic and neurocognitive foundations of emotion abnormalities in bipolar disorder. | Van Rheenen TE et al. | — | 2013 | → |
| Genetics and psychiatry: a proposal for the application of the precautionary principle. | Porteri C | — | 2013 | → |
| Genetics of bipolar disorder. | Craddock N et al. | — | 2013 | → |
| Genetic variants on 3q21 and in the Sp8 transcription factor gene (SP8) as susceptibility loci for psychotic disorders: a genetic association study. | Kondo K et al. | — | 2013 | → |
| Genome-wide association study meta-analysis of European and Asian-ancestry samples identifies three novel loci associated with bipolar disorder. | Chen DT et al. | — | 2013 | → |
| Genome-wide significant associations in schizophrenia to ITIH3/4, CACNA1C and SDCCAG8, and extensive replication of associations reported by the Schizophrenia PGC. | Hamshere ML et al. | — | 2013 | → |
| Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis. | Cross-Disorder Group of the Psychiatric Genomics Consortium | — | 2013 | → |
| Possible associations of NTRK2 polymorphisms with antidepressant treatment outcome: findings from an extended tag SNP approach. | Hennings JM et al. | — | 2013 | → |
| Refinement of chromosome 3p22.3 region and identification of a susceptibility gene for bipolar affective disorder. | Secolin R et al. | — | 2013 | → |
| Selected rapporteur summaries from the XX World Congress of Psychiatric Genetics, Hamburg, Germany, October 14-18, 2012. | Anderson-Schmidt H et al. | — | 2013 | → |
| The genetic basis of depression. | Hodgson K et al. | — | 2013 | → |
| The implications of genomics on the nursing care of adults with neuropsychiatric conditions. | Schutte DL et al. | — | 2013 | → |
| A genome-wide association study of attempted suicide. | Willour VL et al. | — | 2012 | → |
| Animal models of stress vulnerability and resilience in translational research. | Scharf SH et al. | — | 2012 | → |
| ANK3 and CACNA1C--missing genetic link for bipolar disorder and major depressive disorder in two German case-control samples. | Kloiber S et al. | — | 2012 | → |
| Behavioral genetics of affective and anxiety disorders. | Domschke K et al. | — | 2012 | → |
| Genetic architectures of psychiatric disorders: the emerging picture and its implications. | Sullivan PF et al. | — | 2012 | → |
| Genetic heterogeneity according to age at onset in bipolar disorder: a combined positional cloning and candidate gene approach. | Dizier MH et al. | — | 2012 | → |
| Genome wide association studies (GWAS) and copy number variation (CNV) studies of the major psychoses: what have we learnt? | Lee KW et al. | — | 2012 | → |
| Genome-wide association study of Alzheimer's disease with psychotic symptoms. | Hollingworth P et al. | — | 2012 | → |
| Genome-wide association study of major depressive disorder: new results, meta-analysis, and lessons learned. | Wray NR et al. | — | 2012 | → |
| Interaction networks of lithium and valproate molecular targets reveal a striking enrichment of apoptosis functional clusters and neurotrophin signaling. | Gupta A et al. | — | 2012 | → |
| Molecular sex differences in human serum. | Ramsey JM et al. | — | 2012 | → |
| Prediction of susceptibility to major depression by a model of interactions of multiple functional genetic variants and environmental factors. | Wong ML et al. | — | 2012 | → |
| Protracted abstinence from distinct drugs of abuse shows regulation of a common gene network. | Le Merrer J et al. | — | 2012 | → |
| Recent genomic advances in schizophrenia. | Doherty JL et al. | — | 2012 | → |
| Research Highlights: Highlights from the latest articles in psychiatric genetics. | Antypa N | — | 2012 | → |
| A 3p26-3p25 genetic linkage finding for DSM-IV major depression in heavy smoking families. | Pergadia ML et al. | — | 2011 | → |
| Database of genetic studies of bipolar disorder. | Piletz JE et al. | — | 2011 | → |
| Drosophila as a model organism for the study of neuropsychiatric disorders. | O'Kane CJ | — | 2011 | → |
| Gene expression and genetic variation data implicate PCLO in bipolar disorder. | Choi KH et al. | — | 2011 | → |
| Genetics of bipolar disorder. | Wendland JR et al. | — | 2011 | → |
| Genome-wide association analysis of age at onset and psychotic symptoms in bipolar disorder. | Belmonte Mahon P et al. | — | 2011 | → |
| Genome-wide association of bipolar disorder suggests an enrichment of replicable associations in regions near genes. | Smith EN et al. | — | 2011 | → |
| Genome-wide association study on bipolar disorder in the Bulgarian population. | Yosifova A et al. | — | 2011 | → |
| Genome-wide searches for bipolar disorder genes. | Alsabban S et al. | — | 2011 | → |
| Genomics and pharmacogenomics of schizophrenia. | Cacabelos R et al. | — | 2011 | → |
| Measures of current alcohol consumption and problems: two independent twin studies suggest a complex genetic architecture. | Dick DM et al. | — | 2011 | → |
| Meta-analysis of genome-wide association studies identifies common variants in CTNNA2 associated with excitement-seeking. | Terracciano A et al. | — | 2011 | → |
| Modifiers and subtype-specific analyses in whole-genome association studies: a likelihood framework. | Lee PH et al. | — | 2011 | → |
| Most genome-wide significant susceptibility loci for schizophrenia and bipolar disorder reported to date cross-traditional diagnostic boundaries. | Williams HJ et al. | — | 2011 | → |
| Nominal association between a polymorphism in DGKH and bipolar disorder detected in a meta-analysis of East Asian case-control samples. | Takata A et al. | — | 2011 | → |
| Personalized medicine can pave the way for the safe use of CB₁ receptor antagonists. | Lazary J et al. | — | 2011 | → |
| Post-traumatic stress disorder is associated with PACAP and the PAC1 receptor. | Ressler KJ et al. | — | 2011 | → |
| Random-effects model aimed at discovering associations in meta-analysis of genome-wide association studies. | Han B et al. | — | 2011 | → |
| Replication of association of 3p21.1 with susceptibility to bipolar disorder but not major depression. | Breen G et al. | — | 2011 | → |
| The genetic blueprint of major depressive disorder: contributions of imaging genetics studies. | Scharinger C et al. | — | 2011 | → |
| A new statistic to evaluate imputation reliability. | Lin P et al. | — | 2010 | → |
| Depression symptom severity and error-related brain activity. | Olvet DM et al. | — | 2010 | → |
| Duplication of the SLIT3 locus on 5q35.1 predisposes to major depressive disorder. | Glessner JT et al. | — | 2010 | → |
| From predisposition to illness: genetically sensitive intermediate pathways to mood disorders. | Duffy A | — | 2010 | → |
| Genome-wide association study of suicide attempts in mood disorder patients. | Perlis RH et al. | — | 2010 | → |
| Imaging genetics: implications for research on variable antidepressant drug response. | Rabl U et al. | — | 2010 | → |
| Overview of the genetics of major depressive disorder. | Lohoff FW | — | 2010 | → |
| Pharmacogenomics of mood stabilizers in the treatment of bipolar disorder. | Squassina A et al. | — | 2010 | → |
| Selected summaries from the XVII World Congress of Psychiatric Genetics, San Diego, California, USA, 4-8 November 2009. | Amstadter AB et al. | — | 2010 | → |
| Synthetic associations in the context of genome-wide association scan signals. | Orozco G et al. | — | 2010 | → |
| The DAOA/G30 locus and affective disorders: haplotype based association study in a polydiagnostic approach. | Gawlik M et al. | — | 2010 | → |
| [The future of depression research]. | Holsboer F | — | 2010 | → |